The DOI matches its Crossref record.
The action of the protein kinase C inhibitor, staurosporine, on human platelets. Evidence against a regulatory role for protein kinase C in the formation of inositol trisphosphate by thrombin
Open accessAbstract
The ability of several putative inhibitors of protein kinase C (PKC) to block dioctanoylglycerol (DC8)-induced phosphorylation of a 47 kDa protein (a recognized substrate for PKC) in human platelets was investigated. Staurosporine (1 microM) caused complete inhibition of phosphorylation, whereas the other reagents were either inactive (polymyxin B) or gave only partial inhibition (C-1, H-7, tamoxifen). Staurosporine (1 microM) fully inhibited the phosphorylation of the 47 kDa protein in platelets challenged with thrombin, but also inhibited the phosphorylation of a 20 kDa protein which is a substrate for myosin light-chain kinase. The inhibition of both kinases by staurosporine was associated with the inhibition of thrombin-induced secretion of ATP and 5-hydroxytryptamine and a slowing of the aggregation response; staurosporine, however, had no effect on the formation of phosphatidic acid and inositol phosphates induced by thrombin. Staurosporine also reversed the inhibitory action of phorbol esters on thrombin-induced formation of phosphatidic acid. These data are consistent with a role for these two kinases in secretion and aggregation (although there must be additional control signals, since aggregation was only slowed, not inhibited), but suggest that neither kinase is involved in the regulation of phosphoinositide metabolism. This latter conclusion contradicts previous observations that the activation of PKC by phorbol esters or membrane-permeable diacylglycerols alters the apparent activity of both phospholipase C and inositol trisphosphatase. Possible explanations for this discrepancy are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C
Toullec, D., Pianetti, P., Coste, H., Bellevergue, P., Grand-Perret, T., Ajakane, M., Baudet, V., Boissin, P., Boursier, E., & Loriolle, F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98476-0 · Cited by 2,456
Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases
Rüegg, U. T., & Gillian, B. (1989) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(89)90263-0 · Cited by 897
Activation of Platelet Function Through G Protein–Coupled Receptors
Offermanns, S. (2006) · Circulation Research · doi:10.1161/01.res.0000251742.71301.16 · Cited by 725
Potent selective inhibitors of protein kinase C
Davis, P. D., Hill, C. H., Keech, E., Lawton, G., Nixon, J. S., Sedgwick, A. D., Wadsworth, J., Westmacott, D., & Wilkinson, S. E. (1989) · FEBS Letters · doi:10.1016/0014-5793(89)81494-2 · Cited by 477
Yatomi, Y., Ruan, F., Hakomori, S., & Igarashi, Y. (1995) · Blood · doi:10.1182/blood.v86.1.193.bloodjournal861193 · Cited by 435
[28] Use and specificity of staurosporine, UCN-O1, and calphostin C as protein kinase inhibitors
Tamaoki, T. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)01030-6 · Cited by 330
Metabolism of the inositol phosphates produced upon receptor activation
Shears, S. B. (1989) · Biochemical Journal · doi:10.1042/bj2600313 · Cited by 302
Citi, S. (1992) · The Journal of cell biology · doi:10.1083/jcb.117.1.169 · Cited by 275
Brown, W. J., DeWald, D. B., Emr, S. D., Plutner, H., & Balch, W. E. (1995) · The Journal of cell biology · doi:10.1083/jcb.130.4.781 · Cited by 262
Phosphorylation of JAK2 in thrombin-stimulated human platelets
Rodríguez-Liñares, B., & Watson, S. P. (1994) · FEBS Letters · doi:10.1016/0014-5793(94)00983-x · Cited by 53
Self-citation
Metadata
- Authors
- Watson, S. P., McNally, J., Shipman, L. J., & Godfrey, P. P.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1988-01-15
- Volume
- 249
- Issue
- 2
- Pages
- 345-350
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1822167571
- Cited by
- 217
- References
- 0
- FWCI
- 12.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.